Editor

8390 POSTS
0 COMMENTS

How AI Might Assist Deal with Overtreatment in Gastrointestinal Most cancers Care

Dr. William A. Corridor sat down with CURE for a dwell interview on the 2026 ASCO Gastrointestinal Cancers Symposium to debate the...

High 5 Blood Most cancers Tales of 2025

Final yr introduced notable developments in blood most cancers remedy and analysis, highlighting a number of myeloma, lymphoma, leukemia and myelodysplastic syndromes....

Efficiency Standing Related With Affected person-Reported Outcomes in Gastric/GEJ Adenocarcinoma

Amongst sufferers with gastric or gastroesophageal junction (GEJ) adenocarcinoma, these with a baseline ECOG efficiency standing of 1 skilled worsened patient-reported outcomes...

Ziihera-Based mostly Trial Outcomes Might Shift Care in HER2+ GI Most cancers Care

On the 2026 ASCO Gastrointestinal Cancers Symposium, Dr. Elena Elimova sat down for an unique interview with CURE to debate outcomes from...

FDA Grants Orphan Drug Designation to CK0804 for Myelofibrosis

The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to CK0804, an investigational regulatory T cell remedy developed by...

Editor

8390 POSTS
0 COMMENTS
spot_img